Director Interventional Cardiology
Maasstad Ziekenhuis
Rotterdam, Netherlands
Dr. Pieter Smits is an interventional cardiologist for more than 20 years and currently the Director of the Interventional Cardiology Department of the Maasstad Hospital, Rotterdam, The Netherlands. He has been the principal investigator for multiple large scale randomized controlled DES trials like: COMPARE, COMPARE II, COMPARE-ACUTE, COMPARE-ABSORB and Chairman of COMPARE-CRUSH. He has been very active in the field of bioresorbable scaffolds from the very beginning and expierenced operator in complex lesions.
Currently he is co-PI of the MASTER-DAPT trial, a 4300 pts global RCT in high bleeding risk (HBR) patients on DAPT regimens post PCI and PI of the current enrolling multicenter trial COMPARE 60/80 HBR, looking at potential benefit of ultrathin struts and shortened DAPT in HBR PCI population.
Saturday, February 25, 2023
2:32 PM – 3:15 PM ET
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Saturday, February 25, 2023
3:15 PM – 4:40 PM ET
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Saturday, February 25, 2023
3:55 PM – 4:03 PM ET
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Saturday, February 25, 2023
4:27 PM – 4:40 PM ET
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Saturday, February 25, 2023
7:24 PM – 7:32 PM ET
Disclosure information not submitted.
Saturday, February 25, 2023
7:40 PM – 7:55 PM ET
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sunday, February 26, 2023
4:54 PM – 5:18 PM ET
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sunday, February 26, 2023
5:34 PM – 5:42 PM ET
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sunday, February 26, 2023
5:42 PM – 5:55 PM ET
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)